Please disable your adblock and script blockers to view this page

Parkinson's: Study examines the potential of spinal cord stimulation


DBS
Bioelectronic Medicine
participants’
Medtronic
Abbott
Boston Scientific
Kyowa Kirin
Boehringer Ingelheim
AbbVie
FP Pharmaceutical

No matching tags

No matching tags

No matching tags

No matching tags


the United States
U.S.
Japan

No matching tags

Positivity     35.51%   
   Negativity   64.49%
The New York Times
SOURCE: https://www.medicalnewstoday.com/articles/parkinsons-study-examines-the-potential-of-spinal-cord-stimulation
Write a review: www.medicalnewstoday.com
Summary

They have published their findings in the journal Bioelectronic Medicine.The researchers set out to determine whether spinal cord stimulation could be a singular therapy for Parkinson’s disease and a salvage therapy, in people for whom DBS is increasingly ineffective.The study included 15 participants, with a mean age of 74 years. However, those who chose the cycling mode had a 7% worsening in these scores.While many of the results seem promising, it is important to note that spinal cord stimulation carries some risks and may cause complications, including bleeding at the site of insertion.The researchers also acknowledge that their study design had a limitation: They were unable to determine whether the improvements in scores stemmed from the stimulation itself or the resulting decrease in pain, which allowed for more mobility.The team of researchers, based in the U.S. and Japan, observe:“Spinal cord stimulation is an emerging technology that can potentially be utilized to treat both the motor and nonmotor symptoms, such as pain, that patients with Parkinson’s disease deal with on a daily basis.”Another limitation involved the fact that the patients did not receive the spinal cord stimulators in the exact same location, due to differences in how their pain presented.

As said here by https://www.medicalnewstoday.com/articles/parkinsons-study-examines-the-potential-of-spinal-cord-stimulation